21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Stable, non-corrosive formulations for pressurized metered dose inhalers
#5402DEUTERATED WATER AND RIBOFLAVIN SOLUTION FOR EXTENDING SINGLET OXYGEN LIFETIMES IN TREATMENT OF OCULAR TISSUE AND METHOD OF USE
#5403THERAPEUTIC REGIMEN FOR TREATING CANCER
#5404Derivatives of N-hydroxybenzamide for treating HIV infections
#5405Cannabinoid-Containing Compositions and Methods for Their Use
#5406METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES
#5407Permeation enhancers for topical formulations
#5408Novel NIDDM Regimen
#5409BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ONDANSETRON
#5410PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT/PROPHYLAXIS OF NON-ALCOHOLIC FATTY LIVER DISEASE
#5411Use of Flubendazole and Vinca Alkaloids for Treatment of Hematological Diseases
#5412METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS
#5413Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer
#54146-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
#5415COMBINATION
#5416PHARMACEUTICAL COMPOSITION HAVING THE ACTIVE SUBSTANCES METFORMIN AND SITAGLIPTIN OR VILDAGLIPTIN
#5417COMBINATION THERAPY USING A BETA 3 ADRENERGIC RECEPTOR AGONISTS AND AN ANTIMUSCARINIC AGENT
#5418Method for combating adverse effects arising from antipsychotic treatment
#5419MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS
#5420USE OF AT LEAST ONE OMEGA-3 FATTY ACID AND OF AT LEAST ONE POLYPHENOL FOR THE ENDOGENOUS SYNTHESIS OF EICOSAPENTANOIC ACID AND DOCOSAHEXANOIC ACID
#5421ANIMAL FEEDS AND VETERINARY COMPOSITIONS
#5422HYALURONIC ACID BASED MUCOADHESIVE THERAPEUTIC COMPOSITION FOR THE PREVENTION AND TREATMENT OF EPITHELIAL AND MUCOSAL LESIONS OF THE HUMAN BODY
#5423DUAL ANTAGONISM OF ENDOTHELIN TYPE A AND BRADYKININ B1 RECEPTORS FOR TREATING PAIN AND PREVENTING CARTILAGE DEGRADATION
#5424METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS
#5425Therapy for enteric infections
#5426COMPOSITIONS COMPRISING CYCLIC AMP ENHANCERS AND/OR EP LIGANDS, AND METHODS OF PREPARING AND USING THE SAME
#5427Quality of life of hepatitis C patients with a formulation for administration to the oral mucosa including freeze dried lysate of selected or species and N-acetyl D-glucosamine
#5428THERAPEUTIC COMPOSITION
#5429SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVES THEREOF AND HIGH-MONACOLIN K CONTENT RED YEAST RICE EXTRACT
#5430Herbal composition comprising ginger and goldenrod for the treatment of cold and flu
#5431Five part herbal cleanse protocol (detoxifying tea, tonifying tea, relaxing tea, parasite tea, intestinal tea) in conjunction with yoga and a vegan alkalinizing food and juice cleanse program
#5432Nitroxyl Progenitors in the Treatment of Heart Failure
#5433SKIN EXTERNAL COMPOSITION COMPRISING A SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND THE USE THEREOF
#5434CYTOPROTECTIVE OR THERAPEUTIC PLANT COMPOSITION
#5435Topical Antibiotic Formulations
#5436Composition for inducing tissue regeneration by activating platelet-rich plasma (PRP)
#5437Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells
#5438Pharmaceutical formulation
#5439Extracts, fractions and compositions comprising acetogenins and their applications
#5440Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
#5441Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
#5442Method
#5443Compositions and methods for treating macular edema
#5444TUMOR TREATMENT
#5445Treatment of Gastrointestinal Inflammation and Psoriasis and Asthma
#5446Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis
#5447METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST
#5448METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST
#5449TISSUE KALLIKREIN FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER
#54503-substituted compounds for reducing uric acid
#5451Co-enzyme Q10 formulations and methods of use
#5452Methods and Devices for Sustained In-Vivo Release Of an Active Agent
#5453COMPOSITIONS AND METHODS AND USES RELATED THERETO
#5454Agent for reducing risk of developing cancer
#5455METHODS FOR THE USE OF STEM CELLS AND STEM CELL FACTORS IN THE TREATMENT OF SKIN CONDITIONS
#5456T. CRUZI-DERIVED NEUROTROPHIC AGENTS AND METHODS OF USE THEREFOR
#5457ANTIHISTAMINE AND ANTIHISTAMINE-LIKE NASAL APPLICATION, PRODUCTS
#5458System and method for diagnosis and treatment
#5459METHOD FOR TREATING MULTIPLE SCLEROSIS
#5460Method for treatment of hair loss with a combination of natural ingredients
#5461Tobacco compositions
#5462Methods and apparatus for drug modeling and displaying drug models
#5463Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
#5464Treatment of ophthalmic disorders using urea
#5465Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism
#5466Treatment for multiple sclerosis
#5467RED YEAST RICE EXTRACT HIGH IN MONACOLIN K CONTENT
#5468Treatment for oxidative stress and/or hypertension
#5469METHODS AND COMPOSITIONS FOR IMPROVED RIFAMYCIN THERAPIES
#5470Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer
#5471Compounds that treat malaria and prevent malaria transmission
#5472Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
#5473Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors
#5474COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#5475PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES
#5476Combination therapy
#5477COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR
#5478ASSOCIATION OF A SINUS NODE If CURRENT INHIBITOR AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
#5479Compositions and methods for treating, reducing, ameliorating, or preventing infections
#5480Method of treating frailty
#5481KITS AND IMPROVED COMPOSITIONS FOR TREATING LOWER URINARY TRACT DISORDERS
#5482Method of using β-hydroxy-β-methylbutyrate for the treatment of disease conditions
#5483SENSITIZATION OF CANCER CELLS TO TREATMENT
#5484METHOD AND FORMULATION FOR THE CONTROL OF PARASITES
#5485Glycoside derivative and uses thereof
#5486VETERINARY PHARMACEUTICAL COMPOSITION AND METHOD (ALTERNATIVES) FOR THE PROPHYLAXIS AND TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT AND INTOXICATIONS OF DIVERSE ETIOLOGY IN ANIMALS
#5487Wound-healing, anti-ambustial, regenerating, and anti-viral pharmaceutical formula for local administration
#5488Combinations of Hepatitis C Virus Inhibitors
#5489COMBINATION THERAPIES USING ANTIBACTERIAL AMINOGLYCOSIDE COMPOUNDS
#5490Method for modulating activity of T lymphocytes
#5491COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3
#5492Carboxymethylarginine Production Inhibitor and Collagen Denaturation Inhibitor
#5493SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING EPA OR DERIVATIVES THEREOF, OPTIONALLY, DHA OR DERIVATIVES THEREOF AND MONACOLIN K
#5494Preventing or treating periodontal diseases by herbal extract
#5495DIAGNOSIS AND TREATMENT OF THE PRODROMAL SCHIZOPHRENIC STATE
#5496Treatment of specific cardiovascular conditions with nitrite
#5497Injectible, biocompatible synthetic bone growth composition
#5498Method, composition and package for bowel cleansing
#5499CAPCNA PEPTIDE THERAPEUTICS FOR CANCER
#5500METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION
#5501Ophthalmic formulations and uses thereof
#5502Method for Preparing Mechanically Macerated Demineralized Bone Materials and Compositions Comprising the same
#5503Homeopathic formulations for treatment of herpes virus symptoms
#5504TREATMENT OF ACNE BY CONDITIONED MEDIA
#5505Solid dosage form comprising a fibrate
#5506HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES
#5507Use of spinosyns and spinosyn compositions against herpesviridae viral infections
#5508Post-exposure therapy of influenza A infections
#5509Sublingual films
#5510Topical skin care compositions and methods
#5511Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly
#5512DOSAGE FORMS OF ACTIVE INGREDIENTS CONTAINING HYDROXYSTILBENE FOR TREATING MENOPAUSAL COMPLAINTS
#5513PARENTERAL COMPOSITION COMPRISING MICROSPHERES WITH A DIAMETER BETWEEN 10 AND 20 MICRONS
#5514FORMULATIONS AND METHODS FOR RECOVERY FROM DENTAL SURGERY
#5515MICROBUBBLE ASSISTED VIRAL DELIVERY
#5516Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#5517Deoxycorticosterone induced elastin production
#5518Method of treatment of cancer patients
#5519Modulation of synaptic maintenance
#5520METHODS OF ATTENUATING THE LOSS OF FUNCTIONAL STATUS
#5521STABLE AQUEOUS SUSPENSION
#5522Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects
#5523Method of treating patients with cardiovascular illness
#5524METHODS FOR UP-REGULATING ANTIGEN EXPRESSION IN TUMORS
#5525Granulysin in immunotherapy
#5526Myocardial perfusion imaging methods and compositions
#5527Uses of IL-12 in hematopoiesis
#5528EXO-S-MECAMYLAMINE METHOD, USE, AND COMPOUND FOR TREATMENT
#5529Method for treating eczema
#5530EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
#5531COMPOUNDS AND COMPOSITIONS FOR TREATING INFECTION
#5532Methods and compositions to reduce oxidative stress
#5533Combination Therapy With Parp Inhibitors
#5534METHODS OF TREATING MOTOR DISORDERS WITH ALPHA-2B ANDRENERGIC RECEPTOR AGONISTS
#5535Methods and compositions for increasing the anaerobic working capacity in tissues
#5536Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
#5537Inhibitors of fatty acid binding protein (FABP)
#5538PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES
#5539INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS
#5540Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
#5541Androgen composition for treating an opthalmic condition
#5542Method And Composition For The Treatment Of Adverse Skin Conditions
#5543Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
#5544Compositions Comprising Thalidomide and Artemisinin for the Treatment of Cancer
#5545Carbohydrate composition for flat glucose response
#5546Methods of treating hematologic cancers
#5547COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS
#5548Composition for prophylaxis or treatment of urinary system infection and method thereof
#5549Monophosphorylated lipid A derivatives
#5550Anti-bacterial infection, inflammation, and leukemia composition and use thereof
#5551ORGAN ARREST, PROTECTION, PRESERVATION AND RECOVERY
#5552Nutritional Composition for Lactating Women
#5553Topical skin care formulations comprising botanical extracts
#5554Herbal composition for reducing ADD/ADHD and method thereof
#5555Dietary supplement stimulating the male sexual function
#5556Methods and compositions for heavy metal detoxification
#5557Pharmaceutical composition for dissolving and eliminating pathological tissues and pathogens and its usage
#5558Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting
#5559Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting
#5560COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE AND USES THEREOF
#5561Compositions including beta-hydroxy-beta-methylbutyrate
#5562ANTIBACTERIAL COMPOSITIONS
#5563Compositions and soft tissue replacement methods
#5564Enzyme Delivery Systems and Methods of Preparation and Use
#5565COMBINATION THERAPY WITH THIOCOLCHICINE DERIVATIVES
#5566Drug carrier and drug carrier kit for inhibiting fibrosis
#5567Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein
#5568Skincare compositions
#5569Inhibition of biofilm organisms
#5570POLYPEPTIDES AND USES THEREOF
#5571USE OF AEROSOLIZED CYCLOSPORINE FOR PREVENTION AND TREATMENT OF PULMONARY DISEASE
#5572Active agent complex and formulation comprising the active agent complex
#5573COMBINATION ANTI-CANCER THERAPY
#5574Methods for Treating or Preventing Malaria by Administering an Antibody that Specifically Binds Angiopoietin-2 (Ang-2)
#5575Pharmaceutical composition for treating ischemic events
#5576TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS
#5577Inhibitors of filovirus entry into host cells
#5578COMPOSITIONS AND METHODS FOR TREATING CANCER WHILE PREVENTING OR REDUCING CARDIOTOXICITY AND/OR CARDIOMYOPATHY
#5579METHOD OF REGULATING FERTILIZING ABILITY USING CYCLIC ADP-RIBOSE AND CD38
#5580Treatment and prevention of pulmonary conditions
#5581COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
#5582Compositions and soft tissue replacement methods
#5583Compositions and soft tissue replacement methods
#5584Compositions and soft tissue replacement methods
#5585Compositions and Methods for Implantation of Processed Adipose Tissue and Processed Adipose Tissue Products
#5586Human Placental Derived Extracellular Matrix and Uses Therof
#5587METHOD AND COMPOSITION FOR RESTORATION OF AGE-RELATED TISSUE LOSS IN THE FACE OR SELECTED AREAS OF THE BODY
#5588USE OF IL-12 TO INCREASE SURVIVAL FOLLOWING ACUTE EXPOSURE TO IONIZING RADIATION
#55893'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
#5590Oligodendrocyte Production from Multipotent Neural Stem Cells
#5591Methods of using death receptor agonists and EGFR inhibitors
#5592Artemisinin derivatives with natural amino acids, peptides, and amino sugars for skin imperfections and infection in mammals
#5593Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof
#5594PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND CORTICOSTEROIDS
#5595Nitrile derivatives and their pharmaceutical use and compositions
#5596Synthetic synovial fluid compositions and methods for making the same
#5597Method for treating phytophotodermatitis
#5598Antioxidant composition
#5599Methods and formulations for treating ineffective or decreased esophagal motility
#5600Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant
#5601ANTIVIRAL OLIGONUCLEOTIDES
#5602Theophylline derivative inhibits osteoporosis
#5603SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS
#5604LATANOPROST-CONTAINING AQUEOUS EYE DROPS AND METHOD FOR INHIBITING ADSORPTION OF LATANOPROST TO RESIN
#5605Heterocyclic derivatives and their use in the treatment of neurological disorders
#5606COMPOSITIONS COMPRISING SPECIFIC UGT INHIBITORS AND METHODS OF USE THEREOF
#5607COMBINATION THERAPY
#56087-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
#56091,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
#56101,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
#5611TREATMENT OF DISEASES WITH ALTERED SMOOTH MUSCLE CONTRACTILITY
#5612sGC stimulators
#5613"The Use of a PAR-1 Antagonist in Combination with a P2Y12 ADP Receptor Antagonist for Inhibition of Thrombosis"
#5614Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
#5615DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS
#5616MULTIPLE MYELOMA PROGNOSIS AND TREATMENT
#5617Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)
#5618Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#5619Compositions and methods for stimulating wound healing
#5620Compositions for the treatment of hemorrhoids and related diseases
#5621ANTISEPTIC OINTMENT COMPRISING BENTONITE INTERCALATED WITH SILVER, COPPER OR ZINC FOR EXTERNAL APPLICATION
#5622Synergistic combinations to reduce particle dose for targeted treatment of cancer and its metastases
#5623Composition and method for treatment of diabetes
#5624Long acting insulin composition
#5625Matrix for sustained, invariant and independent release of active compounds
#5626Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
#5627Treatment of triple receptor negative breast cancer
#5628Lipid formulation
#5629NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS
#5630HYDROGELS USED TO DELIVER MEDICAMENTS TO THE EYE FOR THE TREATMENT OF POSTERIOR SEGMENT DISEASES
#5631Method of obtaining viable small tissue particles and use for tissue repair
#5632Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use
#5633IL-27 Antagonists for Treating Inflammatory Diseases
#5634TREATMENT OF OVARIAN CANCER USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE
#5635METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER
#5636Use of inhibitors of bruton's tyrosine kinase (Btk)
#5637COMPOSITION FOR PREVENTING OR TREATING LIVER TOXICITY COMPRISING GALGEUNTANG OR LACTIC ACID BACTERIA FERMENTED GALGEUNTANG
#5638Equine nutritional supplement
#5639TREATMENT OF ERECTILE DYSFUNCTION USING PLATELET-RICH PLASMA
#5640Lactic acid bacteria and bifidobacteria for treating endotoxemia
#5641COMPOSITION AND USE OF PROBIOTIC STRAIN GM-263 (ADR-1) IN TREATING RENAL FIBROSIS IN DIABETES
#5642COMBINATION THERAPY FOR LYSOSOMAL STORAGE DISEASES
#5643NOVEL METHOD FOR TREATMENT OF SKIN WOUNDS AND PREPARATIONS FOR IMPLEMENTATION OF SAME
#5644IMMUNOTHERAPY OF B-CELL MALIGNANCIES USING ANTI-CD22 ANTIBODIES
#5645Specific binding proteins and uses thereof
#5646TRANSMUCOSAL DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE THEREOF
#5647PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF
#5648Carbamide peroxide treatments for the reproductive tract
#5649Pharmaceutical formulations containing lipoic acid derivatives
#5650Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells
#5651Compositions and its use in treating obesity or inducing weight loss
#5652ENERGY BEVERAGE WITH CREATINE AND CAFFEINE COMBINATION
#5653Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)
#5654COMPOSITIONS AND METHODS FOR TREATING PROLIFERATIVE DISEASES
#5655Medicaments for inhibiting thrombus formation
#5656Compositions comprising enzyme-cleavable oxycodone prodrug
#5657Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria
#5658Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
#5659Compositions for Reducing the Incidence of Drug Induced Arrhythmia
#5660MIXTURE OF NON-DIGESTIBLE OLIGOSACCHARIDES FOR STIMULATING THE IMMUNE SYSTEM
#5661METHODS FOR TREATING SEPTIC SHOCK
#5662Treating cardiovascular tissue
#5663Anesthesia delivery system
#5664COSMETIC OR DERMOTOLOGICAL COMPOSITION CONTAINING HYDROLYZATES MADE OF PLANT EXTRACTS
#5665Compositions and methods for increasing lifespan and health span
#5666Natural Preparation for Treatment of Skin Sores and Lesions
#5667Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response
#5668MULTIFUNCTIONAL TOPICAL FORMULATION FOR THE TREATMENT OF ACNE VULGARIS AND OTHER SKIN CONDITIONS
#5669NUTRITIONAL COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE
#5670Pediculosis Treatment and Prophylaxis
#5671Methods for inhibiting sensory nerves by topically administering strontium-containing compositions to keratinized skin
#5672Combinations and modes of administration of therapeutic agents and combination therapy
#5673METHOD FOR TREATING A PATIENT IN NEED OF ASPIRIN THERAPY
#5674Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
#5675CONCENTRATION AND MENTAL PERFORMANCE AMPLIFYING FORMULATION
#5676Controlled release formulations of levodopa and uses thereof
#5677WOUND-COVERING MATERIAL
#5678Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity
#5679Nano silver-zinc oxide composition
#5680FUCOSYLLACTOSE AS BREAST MILK IDENTICAL NON-DIGESTIBLE OLIGOSACCHARIDE WITH NEW FUNCTIONAL BENEFIT
#5681IMMUNOMODULATING COMPOSITIONS COMPRISING INTERLEUKIN 13 INHIBITORS AND USES THEREFOR
#5682ANTI-TGF-BETA RECEPTOR II ANTIBODIES
#5683THERAPY FOR ENTERIC INFECTIONS
#5684Mesenchymal stem cell differentiation
#5685Methods of treating inflammatory and autoimmune diseases with natalizumab
#5686Methods for accelerating the healing of connective tissue injuries and disorders
#5687Composition for Health Promoting Compounds
#5688ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT
#5689Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health
#5690Enhancement of Allogeneic Hematopoietic Stem Cell Transplantation
#5691COMPOSITION COMPRISING A HAEMATIC COMPONENT AND ITS USE FOR THE TREATMENT OF DEGENERATIVE JOINT DISEASE
#5692Composition for Providing Relief of Undesired Body Odours
#5693Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
#5694Dissolution aids for oral peptide delivery comprising a biguanide
#5695TREATMENT OF HEPATITIS C VIRUS INFECTIONS
#5696Compositions and methods for inducing or enhancing connective tissue repair
#5697METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
#5698Multimeric IL-15 soluble fusion molecules and methods of making and using same
#5699Polyion complex comprising PHD2 expression inhibiting substance
#5700Co-Therapy for Diabetic Conditions